Comments to FDA: EPA Omega-3 Products in Ethyl Ester or Re-Esterified Triglyceride Form

CHPA respectfully submits comments to the Commission notice regarding public interest issues raised by Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. (“Amarin”) in its Complaint concerning Omega-3 (ω-3) products.